Literature DB >> 15978960

Caring externalities in health economic evaluation: how are they related to severity of illness?

Fredric Jacobsson1, John Carstensen, Lars Borgquist.   

Abstract

In health economic evaluations, altruistic preferences in the form of caring externalities, i.e. that people care about others' health, is usually not taken into account. In this study we examined how people value their own and others' health. This pilot study was carried out by letting people answer willingness to pay (WTP) questionnaires where internal WTP (own health) and altruistic WTP (others' health) were isolated and examined. A common method used in health economic evaluations is cost-utility analysis, which is based on the maximisation of QALYs. QALY maximisation may be appropriate if altruistic preferences are non-existent or if they are linear in relation to internal preferences (QALYs gained). We found evidence for the existence of altruistic preferences and that these preferences were relatively higher for severe health states (and lower for mild states of health) compared to internal preferences, i.e. when severity of illness increased, the relative increase in caring was higher concerning others than oneself. The difference was statistically significant (P<0.001). Our results indicate that more attention and resources should be directed to severe health states, as compared to mild health states, than advocated by internal preferences in order to obtain more efficient resource allocation in the health care sector.

Entities:  

Mesh:

Year:  2005        PMID: 15978960     DOI: 10.1016/j.healthpol.2004.11.008

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  8 in total

1.  Carer preferences in economic evaluation and healthcare decision making.

Authors:  Hareth Al-Janabi; Nikki McCaffrey; Julie Ratcliffe
Journal:  Patient       Date:  2013       Impact factor: 3.883

2.  The Monetary Value of Informal Care: Obtaining Pure Time Valuations Using a Discrete Choice Experiment.

Authors:  Renske J Hoefman; Job van Exel; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

3.  Willingness to pay for adverse drug event regulatory actions.

Authors:  Jacoline Bouvy; Just Weemers; Huub Schellekens; Marc Koopmanschap
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

4.  QALYs and carers.

Authors:  Hareth Al-Janabi; Terry N Flynn; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2011-12       Impact factor: 4.981

5.  Measuring Health Spillovers for Economic Evaluation: A Case Study in Meningitis.

Authors:  Hareth Al-Janabi; Job Van Exel; Werner Brouwer; Caroline Trotter; Linda Glennie; Laurie Hannigan; Joanna Coast
Journal:  Health Econ       Date:  2015-10-14       Impact factor: 3.046

6.  Managing the delivery of venous leg ulcer services: A willingness to pay study.

Authors:  Nyantara Wickramasekera; Simon Palfreyman; Elizabeth Lumley; Arvind Dosanjh; Phil Shackley
Journal:  Health Sci Rep       Date:  2022-06-28

7.  Identification determinant factors on willingness to pay for health services in Iran.

Authors:  Javad Javan-Noughabi; Zahra Kavosi; Ahmad Faramarzi; Mohammad Khammarnia
Journal:  Health Econ Rev       Date:  2017-11-21

8.  Rival perspectives in health technology assessment and other economic evaluations for investing in global and national health. Who decides? Who pays?

Authors:  Anthony Culyer; Kalipso Chalkidou; Yot Teerawattananon; Benjarin Santatiwongchai
Journal:  F1000Res       Date:  2018-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.